Carregant...
Promising genes and variants to reduce chemotherapy adverse effects in acute lymphoblastic leukemia
Almost two decades ago, the sequencing of the human genome and high throughput technologies came to revolutionize the clinical and therapeutic approaches of patients with complex human diseases. In acute lymphoblastic leukemia (ALL), the most frequent childhood malignancy, these technologies have en...
Guardat en:
| Publicat a: | Transl Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Neoplasia Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7720095/ https://ncbi.nlm.nih.gov/pubmed/33290991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100978 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|